Vasoactive effects of methylamine in isolated human blood vessels: Role of semicarbazide-sensitive amine oxidase, formaldehyde, and hydrogen peroxide

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 2 55-2, 2004, Pages

  Conklin, D J ^a   Cowley, H R ^b   Wiechmann, R J ^c   Johnson, G H ^c   Trent, M B ^d   Boor, P J ^d  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF WISCONSIN EAU CLAIRE   (United States)

^c Midelfort Clinic   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Amine metabolism; Coronary artery bypass grafts; Diabetes; H2O 2

Indexed keywords

AMINE; AMINE OXIDASE (COPPER CONTAINING); CYCLIC GMP; FORMALDEHYDE; HYDROGEN PEROXIDE; METHYLAMINE; MONOAMINE OXIDASE INHIBITOR; NITRIC OXIDE; NORADRENALIN; PROSTAGLANDIN; SEMICARBAZIDE;

ADULT; AGE; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; HYPERPOLARIZATION; INTERNAL MAMMARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIAL ARTERY; RAT; SAPHENOUS VEIN; VASODILATATION;

EID: 0942276495     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00690.2003     Document Type: Article

References (53)

1. 2 sensors, and controversies. News Physiol Sci 17: 131-137, 2002.
2. Awasthi S and Boor PJ. Semicarbazide protection from in vivo oxidant injury of vascular tissue by allylamine. Toxicol Lett 66: 157-163, 1993.
3. Baba S, Watanabe Y, Gejyo F, and Arakawa M. High-performance liquid chromatographic determination of serum aliphatic amines in chronic renal failure. Clin Chim Acta 136: 48-56, 1984.
4. Ca channel activity. Am J Physiol Heart Circ Physiol 275: H1283-H1289, 1998.
5. Boomsma F, Derkx FH, van den Meiracker AH, Man in't Veld AJ, and Schalekamp MA. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci (Lond) 88: 675-679, 1995.
6. Boomsma F, van den Meiracker AH, Winkel S, Aanstoot HJ, Batstra MR, Man in't Veld AJ, and Bruining GJ. Circulating semicarbazide-sensitive amine oxidase is raised both in Type I (insulin-dependent), in Type II (non-insulin-dependent) diabetes mellitus and even in childhood Type I diabetes at first clinical diagnosis. Diabetologia 42: 233-237, 1999.
7. Boor PJ, Hysmith RM, and Sanduja R. A role for a new vascular enzyme in the metabolism of xenobiotic amines. Circ Res 66: 249-252, 1990.
8. Boor PJ and Nelson TJ. Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidase. Toxicology 18: 87-102, 1980.
9. Boor PJ, Trent MB, Lyles GA, Tao M, and Ansari GAS. Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase. Toxicology 73: 251-258, 1992.
10. Cable DG, Caccitolo JA, Pfeifer EA, Daly RC, Dearani JA, Mullany CJ, O'Brien T, Orszulak TA, and Schaff HV. Endothelial regulation of vascular contraction in radial and internal mammary arteries. Ann Thorac Surg 67: 1083-1090, 1999.
11. Castillo V, Lizcano JM, and Unzeta M. Presence of SSAO in human and bovine meninges and microvessels. Neurobiology (Bp) 7: 263-272, 1999.
12. Conklin DJ and Boor PJ. Allylamine cardiovascular toxicity: evidence for aberrant vasoreactivity. Toxicol Appl Pharmacol 148: 245-251, 1998.
13. Conklin DJ, Boyce CL, Trent MB, and Boor PJ. Amine metabolism: a novel path to coronary artery vasospasm. Toxicol Appl Pharmacol 175: 149-159, 2001.
14. Conklin DJ, Langford SD, and Boor PJ. Serum and cellular semicarbazide-sensitive amine oxidase in amine metabolism and cardiovascular toxicity. Toxicol Sci 46: 386-392, 1998.
15. Cracowski JL, Stanke-Labesque F, Sessa C, Hunt M, Chavanon O, Devillier P, and Bessard G. Functional comparison of the human isolated femoral artery, internal mammary artery, gastroepiploic artery, and saphenous vein. Can J Physiol Pharmacol 77: 770-776, 1999.
16. Dar MS, Morselli PL, and Bowman ER. The enzymatic systems involved in the mammalian metabolism of methylamine. Gen Pharmacol 16: 557-560, 1985.
17. Ekblom J. Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus. Pharmacol Res 37: 87-92, 1998.
18. Enrique-Tarancon G, Marti L, Morin N, Lizcano JM, Unzeta M, Sevilla L, Camps M, Palacin M, Testar X, Carpene C, and Zorzano A. Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells. J Biol Chem 273: 8025-8032, 1998.
19. Göktürk C, Garpenstrand H, Nilsson J, Nordquist J, Oreland L, and Forsberg-Nilsson K. Studies on semicarbazide-sensitive amine oxidase in patients with diabetes mellitus and in transgenic mice. Biochim Biophys Acta 1647: 88-91, 2001.
20. Gronvall JLE, Garpenstrand H, Oreland L, and Ekblom J. Autoradiographic imaging of formaldehyde adducts in mice: possible relevance for vascular damage in diabetes. Life Sci 63: 759-768, 1998.
21. Hamilton CA, McPhaden AR, Berg G, Pathi V, and Dominiezak Dominiczak AF. Is hydrogen peroxide an EDHF in human radial arteries? Am J Physiol Heart Circ Physiol 280: H2451-H2455, 2001.
22. Hayes BE and Clarke DE. Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats. Res Commun Chem Pathol Pharmacol 69: 71-83, 1990.
23. Hayes BE, Ostrow PT, and Clarke DE. Benzylamine oxidase in normal and atherosclerotic human aortae. Exp Mol Pathol 38: 243-254, 1983.
24. He GW. Arterial grafts for coronary artery bypass grafting: biological characteristics, functional classification, and clinical choice. Ann Thorac Surg 67: 277-284, 1999.
25. Iesaki T, Okada T, Yamaguchi H, and Ochi R. Inhibition of vasoactive amine induced contractions of vascular smooth muscle by hydrogen peroxide in rabbit aorta. Cardiovasc Res 28: 963-968, 1994.
26. Jaakkola K, Kaunismaki K, Tohka S, Yegutkin G, Vanttinen E, Havia T, Pellinlemi LJ, Virolainen M, Jalkanen S, and Salmi M. Human vascular adhesion protein-1 in smooth muscle cells. Am J Pathol 155: 1953-1965, 1999.
27. Kapeller-Adler R and Toda K. Uber das vorkommen von monomethylamine im harn. Biochem Z 248: 403-425, 1932.
28. 2 in aorta isolated from chronically streptozotocin-diabetic rats: effects of antioxidant enzymes and enzyme inhibitors. Free Radic Biol Med 27: 16-27, 1999.
29. Langford SD, Trent MB, Balakumaran A, and Boor PJ. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase. Toxicol Appl Pharmacol 155: 237-244, 1999.
30. Langford SD, Trent MB, and Boor Pj. Cultured vascular smooth muscle cells are resistant to methylamine toxicity: no correlation to semicarbazide-sensitive amine oxidase. Cardiovasc Toxicol 1: 51-60, 2001.
31. Lebrun P, Atwater I, Rosario LM, Herchuelz A, and Malaisse WJ. Dissociation by methylamine of insulin release from glucose-induced electrical activity in isolated mouse islets of Langerhans. Metabolism 34: 1122-1127, 1985.
32. Lewinsohn R, Heinrich Bohm K, Glover V, and Sandler M. A benzylamine oxidase distinct from monoamine oxidase B-widespread distribution in man and rat. Biochem Pharmacol 27: 1857-1863, 1978.
33. Lyles GA. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidase: biochemical, pharmacological and toxicological aspects. Int J Biochem Cell Biol 28: 259-274, 1996.
34. Lyles GA and McDougall SA. The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazine may be related to the inhibition of semicarbazide-sensitive amine oxidase activities. J Pharm Pharmacol 41: 97-100, 1989.
35. Marra I, Herbert P, Santos L, Barros P, and Alves A. Evaluation of biogenic amines in some Portuguese quality wines by HPLC fluorescence detection of OPA derivatives. Am J Enol Vitic 50: 128-132, 1990.
36. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, and Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 290: 909-913, 2002.
37. Meszaros Z, Csanyi A, Vallus G, Szombathy T, Karadi I, and Magyar K. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases. Neurobiology (Bp) 8: 215-223, 2000.
38. Mitchell SC and Zhang AQ. Methylamine in human urine. Clin Chim Acta 312: 107-114, 2001.
39. Precious E, Gunn CE, and Lyles GA. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Biochem Pharmacol 37: 707-713, 1988.
40. Rodriguez-Martinez MA, Garcia-Cohen EC, Baena AB, Gonzalez R, Salaices M, and Marin J. Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanisms involved. Br J Pharmacol 125: 1329-1335, 1998.
41. Salmi M, Yegutkin GG, Lehvonen R, Koskinen K, Salminen T, and Jalkanen S. A cell surface amine oxidase directly controls lymphocyte migration. Immunity 14: 265-276, 2001.
42. Tani T. [Relaxation of vascular smooth muscle induced by formaldehyde.] Nippon Yakurigaku Zasshi 77: 221-230, 1981.
43. Thornalley PJ, McLellan AC, Lo TWC, Benn J, and Sonksen PH. Negative association between erythrocyte reduced glutathione concentration and diabetic complications. Clin Sci (Lond) 91: 575-582, 1996.
44. Wibo M, Duong AT, and Godfraind T. Subcellular location of semicarbazide-sensitive amine oxidase in rat aorta. Eur J Biochem 112: 87-94, 1980.
45. Wingender W. High-performance liquid chromatographic method for the quantitative analysis of a synthetic copolymer with antitumor activity (copovithane) and methylamine in human plasma and urine. J Chromot 273: 319-326, 1983.
46. Yang GH, Wang YM, Chen L, and Yin JY. Emergency treatment and care of 35 patients with monomethylamine poisoning. Chung-Hua, Hu Li Tsa Chih Chinese J Nurs 30: 83-85, 1995.
47. Yu P. Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase. J Pharm Pharmacol 42: 882-884, 1990.
48. Yu PH. Increase of formation of methylamine and formaldehyde in vivo after administration of nicotine and the potential cytotoxicity. Neurochem Res 23: 1205-1210, 1998.
49. Yu PH and Dyck RE. Impairment of methylamine clearance in uremic patients and its nephropathological implications. Clin Nephrol 49: 299-302, 1998.
50. Yu PH, Lai CT, and Zuo DM. Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. Neurochem Res 22: 615-620, 1997.
51. Yu PH, Wright S, Fan EH, Lun ZR, and Gubisne-Harberle D. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim Biophys Acta 1647: 193-199, 2003.
52. Yu PH and Zuo DM. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes 42: 594-603, 1993.
53. Yu PH and Zuo DM. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia 40: 1243-1250, 1997.